Vaccines, Blood & Biologics
Resources for You
Proper Name: Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)
Manufacturer: Sanofi Pasteur, SA, License #1724
- ActHIB vaccine or ActHIB vaccine combined with Sanofi Pasteur Inc. DTP vaccine by reconstitution is indicated for the active immunization of infants and children 2 through 18 months of age for the prevention of invasive disease caused by H influenzae type b and/or diphtheria, tetanus and pertussis
March 28, 2013 Approval Letter - ActHIB
To include changes to the package insert.
November 20, 2009 Approval Letter - ActHIB
Package Insert Revised: Regarding formaldehyde levels.
September 27, 1996 Approval Letter - ActHIB
Reconstitution with Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed, manufactured by Connaught Laboratories, Inc, for immunization of 15-18 month old children.
Summary for Basis of Approval (ActHIB combined with Tripedia) - Tripedia(PDF - 1000KB) Summary Basis for Regulatory Action - ActHIB(PDF - 5.6MB)